Global search | Diasorin

About Diasorin

Shareholders' meeting

List n. 1 - Appointment of the Board of Directors

07/04/25 - 14:00

About Diasorin

Shareholders' meeting

List n. 1 - Appointment of the Board of Statutory Auditors

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

List n. 1 - Appointment of the Board of Statutory Auditors

07/04/25 - 14:00

About Diasorin

Shareholders' meeting

List n. 2 - Appointment Board of Directors

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

List n. 2 - Appointment of the Board of Statutory Auditors

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

List n. 2 - Appointment of the Board of Statutory Auditors

07/04/25 - 14:00

About Diasorin

Shareholders' meeting

List no. 1 - Appointment Board of Directors

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

List no. 1 - Appointment Board of Statutory Auditors

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

List no. 2 - Appointment Board of Statutory Auditors

24/04/19 - 14:00

About Diasorin

Press releases

Lists publication

03/04/19 - 20:18

Other

Investors

Page

LOINC Codes

View page

Immunodiagnostics

Page

Loyalty Shares

View page

About Diasorin

Image gallery

LSN Integral

Download (high) Download (low)

Research laboratory

Newsroom

Image gallery

LSN XL Integral

Download (high) Download (low)

Research laboratory

Newsroom

Image gallery

LTG instruments

Download (high) Download (low)

Research laboratory

Newsroom

Image gallery

LTG TrainingLab

Download (high) Download (low)

Research laboratory

Newsroom

Image gallery

Luigi Cicchese

Download (high) Download (low)

Top Management

Newsroom

Top management

Luigi Cicchese

View page

About Diasorin

Product hub

Luminex

View page

Licensed technologies

Luminex LTG

Page

Luminex Learning Sessions

View page

Service and support

Image gallery

Luminex LTG xMAP INTELLIFLEX^®

Download (high) Download (low)

Instruments

Newsroom

Luminex LTG xMAP INTELLIFLEX<sup>®</sup>_front

Image gallery

Luminex LTG xMAP INTELLIFLEX^®_front

Download (high) Download (low)

Instruments

Newsroom

Page

Luminex Partners

View page

Luminex LTG

Licensed technologies Instruments

Luminex^® 200^™ System

View page

Luminex LTG

Sustainability projects

Mad for Science

View page

Sustainability

Sustainability projects

Mad for Science for Teachers

View page

Sustainability

Licensed technologies Coupling Accessories

Magnetic Separators

View page

Luminex LTG

Molecular diagnostics instruments

MAGPIX^® System

View page

Molecular Diagnostics

Licensed technologies Instruments

MAGPIX^® System

View page

Luminex LTG

Licensed technologies Microspheres

MagPlex^® Microspheres

View page

Luminex LTG

Licensed technologies Microspheres

MagPlex^® Monitoring Microspheres

View page

Luminex LTG

Licensed technologies Microspheres

MagPlex^®-Avidin Microspheres

View page

Luminex LTG

Licensed technologies Microspheres

MagPlex-TAG^TM Microspheres

View page

Luminex LTG

Press releases

Measles and Mumps IgM on LIAISON (available outside the US and Canada only)

10/04/12 - 2:00

Products Immunodiagnostic

Investors

Coverage

MEDIOBANCA

Investors

Events

Mediobanca - 11th Italian CEO Conference

18/06/2025

Milan

Past event

Newsroom

Events

Mediobanca - CEO Conference

19/06/2024

Milan

Past event

Newsroom

Events

Mediobanca - Italian CEO Conference

21/06/2023

Milan

Past event

Newsroom

Events

Mediobanca - Roadshow

18/04/2023

New York

Past event

Newsroom

Events

Mediobanca - Roadshow

19/04/2023

Chicago

Past event

Newsroom

Events

Mediobanca - Roadshow

18/01/2024

New York

Past event

Newsroom

Events

Mediobanca - Roadshow

16/01/2024

New York

Past event

Newsroom

Events

Mediobanca - Roadshow

11/02/2025

Paris

Past event

Newsroom

Events

Mediobanca - Roadshow

21/11/2024

London

Past event

Newsroom

Events

Mediobanca - Virtual Roadshow

03/02/2022

Italy and France

Past event

Newsroom

Events

Mediobanca - Virtual Roadshow

06/04/2022

USA

Past event

Newsroom

Events

Mediobanca 7th Italian CEO Conference

23/06/2021

Past event

Newsroom

Events

Mediobanca Italian CEO Conference

22/06/2022

Past event

Newsroom

Events

Mediobanca Italian CEO Virtual Conference

24/06/2020

Past event

Newsroom

Licensed technologies Microspheres

MicroPlex^® Microspheres

View page

Luminex LTG

Page

Microspheres

View page

Luminex LTG

Page

Microspheres

View page

Luminex LTG

Molecular diagnostics Kits & reagents - By Format

Molecular controls

View page

Molecular Diagnostics

Product hub

Molecular Diagnostics

View page

Molecular

Molecular Diagnostics

Image gallery

Molecular Diagnostics DirectDisc - LARGE

Download (high) Download (low)

Instruments

Newsroom

Image gallery

Molecular Diagnostics LIAISON PLEX^®

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics LIAISON PLEX<sup>®</sup> front

Image gallery

Molecular Diagnostics LIAISON PLEX^® front

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics LIAISON<sup>®</sup> MDX

Image gallery

Molecular Diagnostics LIAISON^® MDX

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics LIAISON<sup>®</sup> MDX_DISC

Image gallery

Molecular Diagnostics LIAISON^® MDX_DISC

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics LIAISON<sup>®</sup> NES

Image gallery

Molecular Diagnostics LIAISON^® NES

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics LIAISON<sup>®</sup> NES FRONT

Image gallery

Molecular Diagnostics LIAISON^® NES FRONT

Download (high) Download (low)

Instruments

Newsroom

Molecular Diagnostics The VERIGENE<sup>®</sup> System

Image gallery

Molecular Diagnostics The VERIGENE^® System

Download (high) Download (low)

Instruments

Newsroom

Image gallery

Molecular Diagnostics UniversalDisc - LARGE

Download (high) Download (low)

Instruments

Newsroom

Page

Molecular diagnostics Video

View page

Molecular diagnostics Kits & reagents - By Format

Molecular reagents (General purpose reagents)

View page

Molecular Diagnostics

Coverage

MORGAN STANLEY

Investors

Events

Morgan Stanley - 21st Annual Global Healthcare Conference

12/09/2023

New York

Past event

Newsroom

Events

Morgan Stanley - 23rd Annual Global Healthcare Conference

09/09/2025

New York

Past event

Investors

Events

Morgan Stanley - CEO Fireside Chat

06/11/2025

Virtual

Past event

Newsroom

Events

Morgan Stanley - European MedTech & Life Sciences Conference

26/02/2024

London

Past event

Newsroom

Events

Morgan Stanley - Roadshow

03/04/2025

London

Past event

Newsroom

Events

Morgan Stanley 20th Annual Global Healthcare Conference

13/09/2022

Past event

Newsroom

Events

Morgan Stanley European MedTech & Services Conference

27/02/2023

London

Past event

Newsroom

Events

Morgan Stanley European MedTech & Services Conference

28/02/2023

London

Past event

Newsroom

Coverage

Morningstar

Investors

Shareholders' meeting

Mrs. Fiorella Altruda - Curriculum vitae

28/04/16 - 14:00

About Diasorin

Presentation

MUREX Acquisition

16/03/10

Investors

Events

MUREX Acquisition

16/03/2010

Past event

Newsroom

Immunodiagnostics product

LIAISON^® Mycoplasma pneumoniae Diagnostic Solution

View page

Immunodiagnostics

Press releases

New anti HBs II (available outside the US and Canada only)

12/01/12 - 1:00

Products Immunodiagnostic

Investors

Press releases

New Chief Financial Officer

10/10/11 - 2:00

Other

Investors

Press releases

New evidence on MeMed BV's role in supporting emergency medicine clinical decisions unveiled at ACEP 2025

08/09/25 - 11:16

Products Immunodiagnostic

Investors

Press releases

New proposal for resolution related to the remuneration of the Board of Statutory Auditors

22/04/22 - 12:37

Financial Disclosures

Investors

Page

News

View page

Page

News

View page

Page

Newsroom

View page

Newsroom

Page

Newsroom press releases

View page

Newsroom

Press releases

NorDiag acquisition

04/05/12 - 2:00

Acquisition / Partnership

Investors

Press releases

North America business growth drives Group revenues and profitability in H1 2020

30/07/20 - 13:16

Financial Data

Investors

Press releases

North America growth drives up revenues and profitability in the first 9 months of 2020

11/11/20 - 12:41

Financial Data

Investors

Press releases

Notice availability By-Laws

07/02/13 - 1:00

Financial Data

Investors

Press releases

Notice availability By-Laws

07/03/13 - 1:00

Financial Data

Investors

Press releases

Notice filing By-Laws and publication operating procedures for loyalty shares

30/05/16 - 2:00

Financial Data

Investors

Press releases

Notice of change in share capital

19/02/11 - 1:00

Financial Data

Investors

Press releases

Notice of change in share capital

09/02/12 - 1:00

Financial Data

Investors

Shareholders' meeting

Notice of Shareholders' Meeting April 27, 2017

27/04/17 - 14:00

About Diasorin

Press releases

Notice pursuant to art. 144-octied, para. 2 of CONSOB regulation No. 1971/1999

04/04/25 - 0:59

Other

Investors

Press releases

Notice pursuant to art. 144-octies, paga 2 of Consob Regulation No. 11971/1999

05/04/22 - 9:51

Other

Investors

Shareholders' meeting

Notice pursuant to Article 144-sexies sec. 5 CONSOB Issuers' Regulation

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Notice Shareholders' Meeting April 28, 2016

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Notice to bondholders - Offer in option and pre-emption

31/03/25 - 14:00

About Diasorin

Shareholders' meeting

Notice to call April 22, 2015

22/04/15 - 14:00

About Diasorin

Shareholders' meeting

Notice to Shareholders - Information regarding the exercise of the withdrawal right

03/03/25 - 13:00

About Diasorin

Press releases

Notice to Shareholders - Information regarding the exercise of the withdrawal right

03/03/25 - 21:05

Other

Investors

Shareholders' meeting

Notice to Shareholders of Diasorin S.p.A. - Notice of offer in option and pre-emption

31/03/25 - 14:00

About Diasorin

Press releases

Notification of changes in share capital

07/02/13 - 1:00

Financial Data

Investors

Press releases

Notification of changes in share capital

07/03/13 - 1:00

Financial Data

Investors

Press releases

Notification of changes in share capital

07/03/12 - 1:00

Financial Data

Investors

Press releases

Notification of changes in share capital

27/06/12 - 2:00

Financial Data

Investors

Shareholders' meeting

Notification of withdrawal

03/03/25 - 13:00

About Diasorin

Molecular diagnostics Kits & reagents

NxTAG^® Gastrointestinal Pathogen Panel

View page

Molecular Diagnostics

Molecular diagnostics Kits & reagents

NxTAG^® Respiratory Pathogen Panel v2

View page

Molecular Diagnostics

Image gallery

Operations

Download (high) Download (low)

Research laboratory

Newsroom

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 22, 2021

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 23, 2018

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 27, 2017

27/04/17 - 14:00

About Diasorin

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 28, 2016

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 28, 2023

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Ordinary Shareholders' Meeting minutes April 29, 2022

16/03/22 - 13:00

About Diasorin

Page

Our professional families

View page

Page

Our story

View page

About Diasorin

Page

Ownership structure

View page

About Diasorin

Page

Page not found

View page

Page

Page test

View page

Events

Pan European mid cap forum

05/06/2008

Past event

Newsroom

Immunodiagnostics product

LIAISON^® Parvovirus B19 Diagnostic Solution

View page

Immunodiagnostics

Page

People Strategy

View page

Careers

Page

Personal Data Protection

View page

About Diasorin

Sustainability projects

Pinocchio Project

View page

Sustainability

Press releases

Postponement of the term for lists of members of the Board of Auditors

14/04/10 - 2:00

Financial Data

Investors

Video gallery

Precision

Watch the video

Group

Newsroom

Image gallery

Precision

Download (high) Download (low)

Research laboratory

Newsroom

Presentation

Presentation - DiaSorin to acquire Luminex Corporation

12/04/21

Investors

Page

Presentations

View page

Investors

Page

Press kit

View page

Newsroom

Press releases

Press Release

06/12/19 - 18:11

Other

Investors

Press releases

Press Release

06/12/19 - 18:12

Other

Investors

Page

Press releases

View page

Investors

Molecular diagnostics Kits & reagents - By Format

Primer Pairs (ASR)

View page

Molecular Diagnostics

Page

Privacy & Cookie Policy

View page

Press releases

Prize for best Italian Company in R&D in the UK

19/01/12 - 1:00

Other

Investors

Page

Procedures

View page

About Diasorin

Product hub

Products & Services

View page

Licensed technologies

Luminex LTG

Press releases

Proposal to enhance the increased voting rights mechanism to support the Company's growth strategy, also by external lines, and reward a shareholder base with a long-term investment horizon

Price sensitive

27/01/25 - 20:14

Other

Investors

Shareholders' meeting

Proposals for resolution - IP Investimenti e Partecipazioni S.r.l.

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Proxy form Shareholders' Meeting April 27, 2017

27/04/17 - 14:00

About Diasorin

Shareholders' meeting

Proxy form Shareholders' Meeting April 28, 2016

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Proxy form Shareholders’ Representative 2015

22/04/15 - 14:00

About Diasorin

Shareholders' meeting

Proxy form Shareholders' Representative Shareholders' Meeting April 27, 2017

27/04/17 - 14:00

About Diasorin

Shareholders' meeting

Proxy form Shareholders' Representative Shareholders' Meeting April 28, 2016

28/04/16 - 14:00

About Diasorin

Press releases

Publication of documents for the Shareholders’ Meeting to be held on January 27, 2026

22/12/25 - 17:18

Other

Investors

Press releases

Publication of Information Document under the provisions of the art. 71 of the CONSOB Regulation n. 11971/1999

22/07/21 - 18:28

Other

Investors

Press releases

Publication of the document for the Ordinary Shareholders' Meeting scheduled on April 29, 2026

25/03/26 - 12:04

Financial Disclosures

Investors

Press releases

Publication of the lists of candidates for the appointment of the Board Directors, the Board of Statutory Auditors and relevant proposals for resolution.

07/04/25 - 13:07

Financial Disclosures

Investors

Press releases

Publication of the lists of candidates for the appointment of the Board of Directors, the Board of Statutory Auditors and relevant proposals for resolution

08/04/22 - 19:13

Financial Disclosures

Investors

Press releases

Publication of the summary report of the votes

07/10/21 - 11:45

Other

Investors

Press releases

Publication of the summary report of the votes cast

02/05/22 - 12:55

Financial Disclosures

Investors

Presentation

Q1 2008 Results Presentation

15/05/08

Investors

Presentation

Q1 2009 Results Presentation

15/05/09

Investors

Presentation

Q1 2010 Results Presentation

14/05/10

Investors

Presentation

Q1 2011 Results Presentation

13/05/11

Investors

Presentation

Q1 2012 Results Presentation

11/05/12

Investors

Presentation

Q1 2013 Results Presentation

10/05/13

Investors

Presentation

Q1 2014 Results Presentation

09/05/14

Investors

Presentation

Q1 2015 Results Presentation

12/05/15

Investors

Presentation

Q1 2016 Results Presentation

09/05/16

Investors

Events

Q1 2017 consolidated results approval

08/05/2017

Corporate event

Past event

Newsroom

Presentation

Q1 2017 Results Presentation

08/05/17

Investors

Presentation

Q1 2018 Results Presentation

08/05/18

Investors

Results

Q1 2018 Results Presentation

Investors

Events

Q1 2019 Results - Conference Call

02/05/2019

Financial calendar

Past event

Newsroom

Presentation

Q1 2019 Results Presentation

09/05/19

Investors

Results

Q1 2019 Results Presentation

Investors

Events

Q1 2020 Results - Conference Call

13/05/2020

Corporate event

Past event

Newsroom

Presentation

Q1 2020 Results Presentation

13/05/20

Investors

Results

Q1 2020 Results Presentation

Investors

Events

Q1 2021 Results - Conference Call

14/05/2021

Corporate event

Past event

Newsroom

Results

Q1 2021 Results Presentation

Investors

Presentation

Q1 2021 Results Presentation

14/05/21

Investors

Events

Q1 2022 Results - Conference Call

06/05/2022

Corporate event

Past event

Newsroom

Results

Q1 2022 Results Presentation

Investors

Presentation

Q1 2022 Results Presentation

06/05/22

Investors

Events

Q1 2023 Results - Conference Call

09/05/2023

Corporate event

Past event

Newsroom

Results

Q1 2023 Results Presentation

Investors

Presentation

Q1 2023 Results Presentation

09/05/23

Investors

Events

Q1 2024 Results - Conference Call

10/05/2024

Corporate event

Past event

Investors

Presentation

Q1 2024 Results Presentation

10/05/24

Investors

Events

Q1 2025 Results - Conference Call

06/05/2025

Corporate event

Past event

Newsroom

Results

Q1 2025 Results Presentation

Investors

Presentation

Q1 2025 Results Presentation

06/05/25

Investors

Results

Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance

Investors

Press releases

Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance

Price sensitive

10/05/24 - 15:21

Financial Data

Investors

Events

Q1'08 report approval

14/05/2008

Financial calendar

Past event

Newsroom

Events

Q1'09 report approval

15/05/2009

Financial calendar

Past event

Newsroom

Events

Q1'11 results approval

13/05/2011

Financial calendar

Past event

Newsroom

Events

Q1'12 results approval

11/05/2012

Financial calendar

Past event

Newsroom

Events

Q1'13 results approval

10/05/2013

Financial calendar

Past event

Newsroom

Press releases

Q1’23 REVENUES CONFIRM GUIDANCE FOR FISCAL YEAR 2023

Price sensitive

09/05/23 - 11:56

Financial Data

Investors

Events

Q2 2024 Results - Conference Call

29/07/2024

Corporate event

Past event

Newsroom

Results

Q2 2024 Results Presentation

Investors

Results

Q2 2025 Results Presentation

Investors

Presentation

Q2 2025 Results Presentation

31/07/25

Investors

Events

Q3 '08 report approval

13/11/2008

Financial calendar

Past event

Newsroom

Events

Q3 '12 results approval

07/11/2012

Financial calendar

Past event

Newsroom

Presentation

Q3 2008 Results Presentation

13/11/08

Investors

Presentation

Q3 2009 Results Presentation

30/10/09

Investors

Presentation

Q3 2010 Results Presentation

05/11/10

Investors

Presentation

Q3 2011 Results Presentation

11/11/11

Investors

Presentation

Q3 2012 Results Presentation

07/11/12

Investors

Presentation

Q3 2013 Results Presentation

08/11/13

Investors

Presentation

Q3 2014 Results Presentation

14/11/14

Investors

Presentation

Q3 2015 Results Presentation

11/11/15

Investors

Events

Q3 2016 consolidated results approval

10/11/2016

Corporate event

Past event

Newsroom

Events

Q3 2024 Results - Conference Call

05/11/2024

Corporate event

Past event

Newsroom

Presentation

Q3 2024 Results Presentation

05/11/24

Investors

Events

Q3'09 report approval

30/10/2009

Financial calendar

Past event

Newsroom

Events

Q3'11 results approval

11/11/2011

Financial calendar

Past event

Newsroom

Events

Q3'13 results approval

08/11/2013

Financial calendar

Past event

Newsroom

Events

Q3'14 Results Conference Call

14/11/2014

Past event

Newsroom

Presentation

Q4 2007 Results Presentation

14/02/08

Investors

Presentation

Q4 2008 Results Presentation

13/02/09

Investors

Presentation

Q4 2009 Results Presentation

12/02/10

Investors

Presentation

Q4 2010 Results Presentation

14/02/11

Investors

Events

Q4 2024 Results - Conference Call

14/03/2025

Corporate event

Past event

Newsroom

Events

Q4'07 results approval

14/02/2008

Financial calendar

Past event

Newsroom

Events

Q4'08 results approval

13/02/2009

Financial calendar

Past event

Newsroom

Events

Q4'12 results approval

14/02/2011

Financial calendar

Past event

Newsroom

Press releases

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems

08/01/18 - 9:00

Acquisition / Partnership

Investors

Press releases

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems

08/01/18 - 9:00

Acquisition / Partnership

Investors

Coverage

RBC

Investors

Events

RBC - Roadshow

03/06/2025

Toronto

Past event

Newsroom

Events

RBC - Roadshow

04/06/2025

Montreal

Past event

Newsroom

Page

Reagents & Accessories

View page

Luminex LTG

Press releases

Record free cash flow generation along with growth in revenues and profitability for DiaSorin in the first 9 months of 2019

06/11/19 - 13:00

Financial Data

Investors

Press releases

Registration and publication the minutes of shareholders' meeting. Withdrawal right.

03/03/25 - 21:19

Other

Investors

Page

Remuneration

View page

About Diasorin

Shareholders' meeting

Report on Corporate Governance 2014

22/04/15 - 14:00

About Diasorin

Reports on corporate governance

Report on Corporate Governance 2020

11/03/21 - 13:00

About Diasorin

Reports on corporate governance

Report on Corporate Governance 2025

20/04/26 - 14:00

About Diasorin

Shareholders' meeting

Report on H1'16 results

28/04/16 - 14:00

About Diasorin

Annual and Interim Reports

Report on Q1'08 Results

03/03/08

Investors

Annual and Interim Reports

Report on Q1'09 Results

31/03/09

Investors

Annual and Interim Reports

Report on Q1'10 Results

14/05/10

Investors

Annual and Interim Reports

Report on Q1'11 Results

13/05/11

Investors

Annual and Interim Reports

Report on Q1'12 Results

31/03/12

Investors

Annual and Interim Reports

Report on Q1'13 Results

22/05/13

Investors

Annual and Interim Reports

Report on Q1'14 Results

15/05/14

Investors

Annual and Interim Reports

Report on Q1'15 Results

18/05/15

Investors

Shareholders' meeting

Report on Q1'15 Results

22/04/15 - 14:00

About Diasorin

Annual and Interim Reports

Report on Q3'08 Results

01/09/08

Investors

Annual and Interim Reports

Report on Q3'09 Results

01/09/09

Investors

Annual and Interim Reports

Report on Q3'10 Results

05/11/10

Investors

Annual and Interim Reports

Report on Q3'11 Results

11/11/11

Investors

Annual and Interim Reports

Report on Q3'12 Results

30/09/12

Investors

Annual and Interim Reports

Report on Q3'13 Results

08/11/13

Investors

Annual and Interim Reports

Report on Q3'14 Results

21/11/14

Investors

Annual and Interim Reports

Report on Q3'15 results

19/11/15

Investors

Shareholders' meeting

Report on Q3'15 results

22/04/15 - 14:00

About Diasorin

Annual and Interim Reports

Report on Q4'08 Results

12/12/08

Investors

Annual and Interim Reports

Report on Q4'09 Results

30/12/09

Investors

Annual and Interim Reports

Report on Q4'10 Results

30/12/10

Investors

Shareholders' meeting

Report on the remuneration policy and fees paid 2019

10/06/20 - 14:00

About Diasorin

Reports on remuneration

Report on the remuneration policy and fees paid 2019

11/05/20 - 14:00

About Diasorin

Shareholders' meeting

Report on the remuneration policy for the year 2021 and remuneration paid in the year 2020

22/04/21 - 14:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2021 and remuneration paid in the year 2020

31/03/21 - 14:00

About Diasorin

Shareholders' meeting

Report on the remuneration policy for the year 2022 and remuneration paid in the year 2021

16/03/22 - 13:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2022 and remuneration paid in the year 2021

07/04/22 - 14:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2023 and remuneration paid in the year 2022

29/04/23 - 14:00

Shareholders' meeting

Report on the remuneration policy for the year 2023 and remuneration paid in the year 2022

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Report on the remuneration policy for the year 2024 and remuneration paid in the year 2023

15/03/24 - 13:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2024 and remuneration paid in the year 2023

24/04/24 - 14:00

About Diasorin

Shareholders' meeting

Report on the remuneration policy for the year 2025 and remuneration paid in the year 2024

24/03/25 - 13:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2025 and remuneration paid in the year 2024

24/03/25 - 13:00

About Diasorin

Reports on remuneration

Report on the remuneration policy for the year 2026 and remuneration paid in the year 2025

25/03/26 - 13:00

About Diasorin

Shareholders' meeting

Report on the remuneration policy for the year 2026 and remuneration paid in the year 2025

25/03/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

27/03/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

10/04/26 - 14:00

About Diasorin

Press releases

Report treasury shares buy-back

03/07/18 - 18:30

Financial Data

Investors

Buy back program

Report Treasury shares buy-back

03/04/26 - 14:00

About Diasorin

Buy back program

Report treasury shares buyback

17/05/24 - 14:00

About Diasorin

Buy back program

Report Treasury shares buy-back

13/02/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

06/02/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

30/01/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

20/03/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

13/03/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

06/03/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

27/02/26 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

20/02/26 - 13:00

About Diasorin

Buy back program

Report treasury shares buy-back

29/08/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

05/09/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

12/09/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

19/09/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

07/12/22 - 13:00

About Diasorin

Buy back program

Report Treasury shares buy-back

09/06/23 - 14:00

About Diasorin

Buy back program

Report Treasury shares buy-back

16/06/23 - 14:00

About Diasorin

Buy back program

Report Treasury shares buy-back

23/06/23 - 14:00

About Diasorin

Buy back program

Report Treasury shares buy-back

30/06/23 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

02/11/21 - 13:00

About Diasorin

Buy back program

Report treasury shares buy-back

05/11/21 - 13:00

About Diasorin

Buy back program

Report treasury shares buy-back

22/04/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buyback

23/05/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buyback

30/05/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

06/06/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

13/06/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

20/06/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

25/07/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

13/08/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

22/08/22 - 14:00

About Diasorin

Buy back program

Report treasury shares buy-back

04/07/18 - 14:00

About Diasorin

Buy back program

Report Treasury shares buy-back

24/04/26 - 14:00

About Diasorin

Page

Reports on Corporate Governance

View page

About Diasorin

Page

Reports on remuneration

View page

About Diasorin

Page

Research Publications

View page

Press releases

Resignation of a Strategic Executive of the Company

29/11/17 - 19:30

Other

Investors

Press releases

Resignation of Chief Financial Officer

01/09/11 - 2:00

Other

Investors

Shareholders' meeting

Resolution Proposals - IP Investimenti e Partecipazioni S.r.l.

07/04/25 - 14:00

About Diasorin

Page

Resources

View page

Sustainability

Press releases

Restart of the buyback program

10/05/24 - 17:54

Other

Investors

Page

Results

View page

Investors

Press releases

Results for Q1'08

15/05/08 - 2:00

Financial Data

Investors

Investor results FY

Results FY 2021

Press releases

Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance

Price sensitive

06/05/25 - 17:41

Financial Data

Investors

Press releases

Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed

Price sensitive

31/07/25 - 16:22

Financial Data

Investors

Press releases

Revenue growth and strong profitability in the first 9 months of 2022 - Full year 2022 Guidance revised upwards

Price sensitive

27/10/22 - 13:44

Financial Data

Investors

Press releases

REVENUE GROWTH, STRONG PROFITABILITY AND ROBUST CASH FLOW GENERATION IN 2022. PROPOSED ORDINARY DIVIDEND OF €1.10 PER SHARE

Price sensitive

27/03/23 - 13:35

Financial Data

Investors

Press releases

Revenues and EBITDA growth in line with FY 2025 Guidance. Proposed ordinary dividend per share of €1.30, +8.3% vs 2024

Price sensitive

20/03/26 - 17:44

Financial Data

Investors

Press releases

Revenues at constant perimeter of consolidation and ex-Covid up 5% at CER in Q2. FY 2023 Guidance Confirmed

Price sensitive

27/07/23 - 13:18

Financial Data

Investors

Press releases

Revenues, Profitability and Cash Flow Generation hit record highs in 2020

Price sensitive

11/03/21 - 15:31

Financial Data

Investors

Image gallery

Rita Maffei

Download (high) Download (low)

Top Management

Newsroom

Top management

Rita Maffei

View page

About Diasorin

Events

Roadshow London - Berenberg

19/03/2019

Corporate event

Past event

Newsroom

Shareholder basis

Rosa Carlo

About Diasorin

Immunodiagnostics product

LIAISON^® Rubella virus Diagnostic Solution

View page

Immunodiagnostics

Press releases

Sale of Flow Cytometry and Imaging business from DiaSorin to Cytek® Biosciences completed

28/02/23 - 16:06

Acquisition / Partnership

Investors

Image gallery

Sample and barcode

Download (high) Download (low)

Research laboratory

Newsroom

Licensed technologies Microspheres

SeroMAP^TM

View page

Luminex LTG

Page

Service & Support

View page

Service and support

Page

Service Contracts

View page

Service and support

Events

Shareholders' meeting

19/12/2012

Past event

Newsroom

Press releases

Shareholders' meeting

20/12/12 - 1:00

Financial Data

Investors

Page

Shareholders' Meeting

View page

About Diasorin

Press releases

Shareholders' meeting 2022

29/04/22 - 16:26

Other

Investors

Press releases

Shareholders' Meeting 2023

28/04/23 - 12:52

Other

Investors

Press releases

Shareholders' Meeting 2024

24/04/24 - 15:38

Other

Investors

Press releases

Shareholders' Meeting 2025

28/04/25 - 16:50

Other

Investors

Press releases

Shareholders' meeting approves FY Results 2012

22/04/13 - 2:00

Financial Data

Investors

Press releases

Shareholders' meeting approves FY Results 2013

23/04/14 - 2:00

Financial Data

Investors

Press releases

Shareholders' meeting approves FY Results 2014

22/04/15 - 2:00

Financial Data

Investors

Press releases

Shareholders' meeting April 22, 2021

22/04/21 - 15:58

Other

Investors

Shareholders' meeting

Shareholders' Meeting April 22, 2021 - Notice

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 22, 2021 - Reports and motions for resolutions

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 22, 2021 - SPAFID proxy form (art. 135-novies TUF)

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 22, 2021 - SPAFID proxy form (Designated Representative)

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 22, 2021 - Summary report of the votes

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 23, 2018 - Explanatory reports and motion for resolutions

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 23, 2018 - Notice to call

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 23, 2018 - Proxy form

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 23, 2018 - Proxy form Shareholders' Representative

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 23, 2018 - Summary report of the votes

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2019 - Explanatory Reports and motions for resolutions

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2019 - Notice to call

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2019 - Proxy form

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2019 - Proxy form Designated Representative

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2019 - Summary report of the votes

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2024 - Explanatory reports and motions for resolutions

15/03/24 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2024 - Notice of call

15/03/24 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2024 - Proxy form pursuant art. 135-novies TUF

15/03/24 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 24, 2024 - Proxy form pursuant art. 135-undecies TUF

13/03/24 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2016 - Summary report on votes

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Answer to the questions submitted by the Shareholder Ms Rosalba Caminiti

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Explanatory reports and motions for resolutions

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Notice

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Proxy form pursuant art. 135-novies TUF

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Proxy form pursuant art. 135-undecies TUF

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2023 - Summary report of the votes

28/04/23 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2025 – Designated Representative proxy form (art. 135-novies TUF)

14/03/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2025 - Designated Representative proxy form (art. 135-undecies TUF)

14/03/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2025 - Explanatory reports and motions for resolutions

14/03/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2025 - Notice

14/03/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 28, 2025 – Summary report on the votes

29/04/25 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - Explanatory reports and motions for resolutions

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - Notice

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - SPAFID proxy form (art. 135-novies TUF)

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - SPAFID proxy form (art. 135-novies TUF) (UPDATED)

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - SPAFID proxy form (Designated Representative)

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - SPAFID proxy form (Designated Representative) (UPDATED)

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2022 - Summary report of the votes

16/03/22 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2026 - Explanatory reports and motions for resolutions

25/03/26 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2026 - Notice

25/03/26 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2026 - SPAFID proxy form (art. 135-novies TUF)

25/03/26 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting April 29, 2026 - SPAFID proxy form (art. 135-undecies TUF)

25/03/26 - 13:00

About Diasorin

Press releases

Shareholders' Meeting date change

21/03/20 - 20:29

Other

Investors

Shareholders' meeting

Shareholders' Meeting February 28, 2025 - By-laws proposed amendments

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 - Explanatory Report pursuant art. 125-ter TUF

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 – Notice of call

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 - Proxy form pursuant art. 135-novies TUF

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 - Proxy form pursuant art. 135-undecies TUF

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 – Q&A

28/01/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting February 28, 2025 – Summary report on the votes

28/02/25 - 13:00

About Diasorin

Press releases

Shareholders' Meeting FY 2015

28/04/16 - 2:00

Financial Data

Investors

Shareholders' meeting

Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (art. 135-novies TUF)

22/12/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (art. 135-undecies TUF)

22/12/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting January 27, 2026 - Explanatory reports and motions for resolutions

22/12/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting January 27, 2026 – Notice of call

22/12/25 - 13:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting January 27, 2026 - Summary report on votes

31/12/25 - 13:00

About Diasorin

Press releases

Shareholders' Meeting June 10, 2020

10/06/20 - 15:40

Other

Investors

Shareholders' meeting

Shareholders' Meeting June 10, 2020 - Explanatory reports and motions for resolutions

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting June 10, 2020 - Notice to call

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting June 10, 2020 - SPAFID proxy form (art. 135-novies TUF)

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting June 10, 2020 - SPAFID proxy form (Designated Representative)

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting June 10, 2020 - Summary report of the votes

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting minutes April 22, 2015

22/04/15 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting minutes April 24, 2019

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting minutes June 10, 2020

10/06/20 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting October 4, 2021 - Notice

04/10/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting October 4, 2021 - Report and motion for resolution

04/10/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting October 4, 2021 - SPAFID proxy form (art. 135-novies TUF)

04/10/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting October 4, 2021 - SPAFID proxy form (Designated Representative)

04/10/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting October 4, 2021 - Summary report of the votes

04/10/21 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting: report and motions for resolutions

22/04/15 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting September 4, 2024 - Explanatory Report pursuant art. 125-ter TUF

29/07/24 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting September 4, 2024 - Notice of call

29/07/24 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting September 4, 2024 - Proxy form pursuant art. 135-novies TUF

29/07/24 - 14:00

About Diasorin

Shareholders' meeting

Shareholders' Meeting September 4, 2024 - Proxy form pursuant art. 135-undecies TUF

29/07/24 - 14:00